Bulk RNAseq on TNBC cells with treatment of Cisplatin or Doxrubicin
We performed bulk RNA sequencing on the human osteosarcoma cell line SaOS2 in an aim to identify the differential expression genes before and after the treatment of Cisplatin/Doxorubicin, or their combination.